Segment Information - Segment Revenue, Operating Loss and Depreciation and Amortization (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Revenue	$ 27,198	$ 26,106	$ 52,131	$ 49,109
Total operating (loss) income	(6,583)	(4,900)	(13,812)	(8,341)
Depreciation and amortization	2,092	2,320	4,214	4,696
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	27,198	26,106	52,131	49,109
Total operating (loss) income	3,423	(1,892)	(7,710)	(2,529)
Depreciation and amortization			4,214	4,696
Operating Segments [Member] | Medical Device [Member]
Segment Reporting Information [Line Items]
Revenue	19,707	18,453	38,725	35,361
Total operating (loss) income	(7,059)	(5,612)	(14,294)	(9,404)
Depreciation and amortization	1,933	2,133	3,886	4,327
Operating Segments [Member] | In Vitro Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue	7,491	7,653	13,406	13,748
Total operating (loss) income	3,636	3,720	6,584	6,875
Depreciation and amortization	75	86	152	172
Corporate Non Segment [Member]
Segment Reporting Information [Line Items]
Total operating (loss) income	(3,160)	(3,008)	(6,102)	(5,812)
Depreciation and amortization	$ 84	$ 101	$ 176	$ 197